Mannatech Profit Margin

The latest profit margin for MTEX is -6.9% as of June 2026. That compares with -4.15% in the prior-year period — down 66.3% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Mannatech's historical trend and sector peers before judging valuation or financial health.

Over the past year, MTEX's profit margin moved from -4.15% to -6.9% — a 66.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mannatech's valuation or profitability profile.

Against Healthcare companies, MTEX currently prints -6.9% for profit margin, while the sector average sits near 21.34%. That is roughly 132.3% below the sector mean. Large gaps often invite a closer look at Mannatech's growth, margins, and balance sheet.

Profit Margin shows how effectively Mannatech converts resources into returns. At -6.9%, MTEX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -4.15% in the prior-year period — down 66.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MTEX's profit margin (-6.9%), review year-over-year change from -4.15%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.